BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36051469)

  • 1. Differences of Clinicopathological Features between Metaplastic Breast Carcinoma and Nonspecific Invasive Breast Carcinoma and Prognostic Profile of Metaplastic Breast Carcinoma.
    Qiu Y; Chen Y; Zhu L; Chen H; Dai Y; Bao B; Tian L; Hao X; Wang J
    Breast J; 2022; 2022():2500594. PubMed ID: 36051469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators.
    Song Y; Liu X; Zhang G; Song H; Ren Y; He X; Wang Y; Zhang J; Zhang Y; Sun S; Liang X; Sun Q; Pang D
    World J Surg Oncol; 2013 Jun; 11():129. PubMed ID: 23738706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study.
    Morgan E; Suresh A; Ganju A; Stover DG; Wesolowski R; Sardesai S; Noonan A; Reinbolt R; VanDeusen J; Williams N; Cherian MA; Li Z; Young G; Palettas M; Stephens J; Liu J; Luff A; Ramaswamy B; Lustberg M
    World J Surg Oncol; 2020 Jan; 18(1):11. PubMed ID: 31937323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
    El Zein D; Hughes M; Kumar S; Peng X; Oyasiji T; Jabbour H; Khoury T
    Clin Breast Cancer; 2017 Aug; 17(5):382-391. PubMed ID: 28529029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
    Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
    Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological characteristics of metaplastic breast cancer - analysis of the basic immunohistochemical profile and comparison with other invasive breast cancer types.
    Budzik MP; Patera J; Sobol M; Czerw AI; Deptała A; Badowska-Kozakiewicz AM
    Breast; 2019 Feb; 43():135-141. PubMed ID: 30553188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma.
    Li Y; Zhang N; Zhang H; Yang Q
    J Clin Pathol; 2019 Jun; 72(6):418-424. PubMed ID: 30872384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features of metaplastic breast carcinoma.
    Hasdemir OA; Tokgöz S; Köybaşıoğlu F; Karabacak H; Yücesoy C; İmamoğlu Gİ
    Adv Clin Exp Med; 2018 Apr; 27(4):509-513. PubMed ID: 29558027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological Features and Prognosis of Metaplastic Breast Carcinoma: Experience of a Major Chinese Cancer Center.
    Zhang Y; Lv F; Yang Y; Qian X; Lang R; Fan Y; Liu F; Li Y; Li S; Shen B; Pringle GA; Zhang X; Fu L; Guo X
    PLoS One; 2015; 10(6):e0131409. PubMed ID: 26115045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metaplastic breast cancer: clinicopathological features and its prognosis.
    Lee H; Jung SY; Ro JY; Kwon Y; Sohn JH; Park IH; Lee KS; Lee S; Kim SW; Kang HS; Ko KL; Ro J
    J Clin Pathol; 2012 May; 65(5):441-6. PubMed ID: 22412048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer.
    Jung SY; Kim HY; Nam BH; Min SY; Lee SJ; Park C; Kwon Y; Kim EA; Ko KL; Shin KH; Lee KS; Park IH; Lee S; Kim SW; Kang HS; Ro J
    Breast Cancer Res Treat; 2010 Apr; 120(3):627-37. PubMed ID: 20143153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique characteristics and failure patterns of metaplastic breast cancer in contrast to invasive ductal carcinoma: a retrospective multicenter case-control study (KROG 13-07).
    Yu JI; Choi DH; Huh SJ; Ahn SJ; Lee JS; Shin KH; Kwon Y; Kim YB; Suh CO; Kim JH; Cho J; Kim IA; Lee JH; Park W
    Clin Breast Cancer; 2015 Apr; 15(2):e105-15. PubMed ID: 25459069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients.
    Bae SY; Lee SK; Koo MY; Hur SM; Choi MY; Cho DH; Kim S; Choe JH; Lee JE; Kim JH; Kim JS; Nam SJ; Yang JH
    Breast Cancer Res Treat; 2011 Apr; 126(2):471-8. PubMed ID: 21287362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metaplastic Carcinoma of the Breast: Analysis of 38 Cases from a Single Institute.
    Hasbay B; Bolat FA; Aytaç HÖ; Aslan H; Purbager A
    Turk Patoloji Derg; 2020; 36(1):23-30. PubMed ID: 31769499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone receptor status does not affect prognosis in metaplastic breast cancer: a population-based analysis with comparison to infiltrating ductal and lobular carcinomas.
    Paul Wright G; Davis AT; Koehler TJ; Melnik MK; Chung MH
    Ann Surg Oncol; 2014 Oct; 21(11):3497-503. PubMed ID: 24838367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metaplastic breast cancer: Prognostic and therapeutic considerations.
    Corso G; Frassoni S; Girardi A; De Camilli E; Montagna E; Intra M; Bottiglieri L; Margherita De Scalzi A; Fanianos DM; Magnoni F; Invento A; Toesca A; Conforti F; Bagnardi V; Viale G; Colleoni MA; Veronesi P
    J Surg Oncol; 2021 Jan; 123(1):61-70. PubMed ID: 33047318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metaplastic carcinoma of the breast.
    Okada N; Hasebe T; Iwasaki M; Tamura N; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kanai Y; Kinoshita T
    Hum Pathol; 2010 Jul; 41(7):960-70. PubMed ID: 20236684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metaplastic Breast Cancer: Molecular Typing and Identification of Potential Targeted Therapies at a Single Institution.
    Edenfield J; Schammel C; Collins J; Schammel D; Edenfield WJ
    Clin Breast Cancer; 2017 Feb; 17(1):e1-e10. PubMed ID: 27568101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spindle cell metaplastic carcinoma of breast: A clinicopathological and immunohistochemical analysis.
    Zhu H; Li K; Dong DD; Fu J; Liu DD; Wang L; Xu G; Song LH
    Asia Pac J Clin Oncol; 2017 Apr; 13(2):e72-e78. PubMed ID: 25483573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma.
    Lai HW; Tseng LM; Chang TW; Kuo YL; Hsieh CM; Chen ST; Kuo SJ; Su CC; Chen DR
    Breast; 2013 Oct; 22(5):968-73. PubMed ID: 23787124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.